Ameritas Investment Partners’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Ameritas Investment Partners’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,917	Closed	-$33K	–	3152
2019 Q1	$33K	Hold	1,917	–	–	﹤0.01%	2110
2018 Q4	$24K	Hold	1,917	–	–	﹤0.01%	2249
2018 Q3	$31K	Hold	1,917	–	–	﹤0.01%	2279
2018 Q2	$25K	Hold	1,917	–	–	﹤0.01%	2397
2018 Q1	$24K	Hold	1,917	–	–	﹤0.01%	2343
2017 Q4	$27K	Hold	1,917	–	–	﹤0.01%	2290
2017 Q3	$30K	Hold	1,917	–	–	﹤0.01%	2199
2017 Q2	$32K	Hold	1,917	–	–	﹤0.01%	2195
2017 Q1	$30K	Buy	+1,917	New	+$27.4K	﹤0.01%	2173

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Ameritas Investment Partners's OXFD Position: Q2 2019 in Review

Ameritas Investment Partners sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2019, closing a stake of 1,917 shares — an estimated $33K sold.

Ameritas Investment Partners first reported a position in OXFD in Q1 2017 and held it in 9 quarters. The position peaked at $33K in Q1 2019. 86 funds tracked by Wall St. Rank hold OXFD as of Q2 2019.

Ameritas Investment Partners reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2019 after selling out during the quarter.
Ameritas Investment Partners sold 1,917 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2019, an estimated $33K.
Ameritas Investment Partners first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2017 and held it in 9 quarters.
Ameritas Investment Partners's Oxford Immunotec Global PLC Ordinary Shares position peaked at $33K in Q1 2019.
86 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2019.

Based on Ameritas Investment Partners's 13F filing for Q2 2019, filed 14 Aug 2019.